How big of a job is this? Unger works on HPV and ME/CFS: could she be retiring or moving elsewhere?
This is a published letter on clinical useful difference: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)60689-2/fulltext
I suspect this, like quite a few therapies, are related to hypnosis and similar things/states. So after being hypnotised, one can train yourself...
This looks like it could be very annoying https://journals.sagepub.com/doi/abs/10.1177/1367493519864745 Ditte Roth Hulgaard1, Charlotte Ulrikka...
I looked through the NICE survey and couldn't see any analyses just on those who had done GET under a specialist:
This study found that 30% of those diagnosed with “CFS/ME” were male which is a little higher than what tends to see in ME/CFS patient...
It’s not clear to me that they will publish responses: https://journals.sagepub.com/pb-assets/cmscontent/INO/N7JA676%20-%20INO%20Flyer_web.pdf
There is this document which I believe went on to be part of the successful bid. I think it may mention changes to the previous rejected/failed...
US prevalence figures may not apply in the U.K. and other countries. I know I remember reading in Canada, US prevalence figures are unlikely to...
I was going to do a screenshot of this to share. Can you fix the typo, please. It’s “Wessely”
This research was funded or part funded by Invest in ME research https://ueaeprints.uea.ac.uk/70522/ Vipond, Daniel (2018) A role for a leaky...
Very minor point: I have no idea what they are taking about with regards to the Deale et al. study.
Table 1. Overview of interventions in the included studies. Table 2. Outcome measures and measuring instruments used. Table 3. ‘Improvement’ and...
I'm not happy with the classification of O'Dowd et al. 2006 as having a “low risk of bias” for “Selective reporting (reporting bias)” for the...
I’m not sure of the classification of the PACE Trial recovery paper as “low risk of bias” for “Selective reporting (reporting bias)” given all...
Cochrane reviews of CBT and (separately) GET for CFS involve tables like Figure 2 [“Summary of risk of bias of included studies”]. My guess is...
Usually several papers on the one trial are normally seen as one trial rather than the way this paper presents them.
What’s the Friedman study?
This is one reason mixed MUS studies will likely have few objective outcome measures that might theoretically be used in trials of ME/CFS alone....
For people who haven’t read the article, there is now an exemption for the ME/CFS study.
Separate names with a comma.
